FDA Pulls Darvon and Darvocet From the Market
Last Friday the FDA announced that Xanodyne Pharmaceuticals had agreed to withdraw propoxyphene – better known by the brand names Darvon and Darvocet – from the U.S. market due to new data showing that the drug can cause serious toxicity to the heart, even when used at therapeutic doses. The FDA concluded that the safety risks of... Read more
